DE60218998D1 - Auf Bläschen basierendes Impfstoff gegen Chlamydia - Google Patents

Auf Bläschen basierendes Impfstoff gegen Chlamydia

Info

Publication number
DE60218998D1
DE60218998D1 DE60218998T DE60218998T DE60218998D1 DE 60218998 D1 DE60218998 D1 DE 60218998D1 DE 60218998 T DE60218998 T DE 60218998T DE 60218998 T DE60218998 T DE 60218998T DE 60218998 D1 DE60218998 D1 DE 60218998D1
Authority
DE
Germany
Prior art keywords
compositions
blister
vaccine
field
chlamydia vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60218998T
Other languages
English (en)
Other versions
DE60218998T2 (de
Inventor
F-X Jacqueline Berthet
Yves Lobet
Jan Poolman
Vincent Verlant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of DE60218998D1 publication Critical patent/DE60218998D1/de
Application granted granted Critical
Publication of DE60218998T2 publication Critical patent/DE60218998T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60218998T 2001-02-08 2002-02-08 Auf Bläschen basierender Impfstoff gegen Chlamydia Expired - Fee Related DE60218998T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0103169.9A GB0103169D0 (en) 2001-02-08 2001-02-08 Vaccine composition
GB0103169 2001-02-08
PCT/EP2002/001356 WO2002062380A2 (en) 2001-02-08 2002-02-08 Chlamydia vaccine composition

Publications (2)

Publication Number Publication Date
DE60218998D1 true DE60218998D1 (de) 2007-05-03
DE60218998T2 DE60218998T2 (de) 2007-12-06

Family

ID=9908382

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60218998T Expired - Fee Related DE60218998T2 (de) 2001-02-08 2002-02-08 Auf Bläschen basierender Impfstoff gegen Chlamydia

Country Status (10)

Country Link
US (2) US20040131625A1 (de)
EP (1) EP1383534B1 (de)
JP (1) JP2004527480A (de)
AT (1) ATE357249T1 (de)
AU (1) AU2002244710A1 (de)
CA (1) CA2436435A1 (de)
DE (1) DE60218998T2 (de)
ES (1) ES2284840T3 (de)
GB (1) GB0103169D0 (de)
WO (1) WO2002062380A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459524B1 (en) * 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
CA2416137C (en) 2000-07-27 2013-01-29 Dan Granoff Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
US7731980B2 (en) 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
US7537772B1 (en) 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
CA2514328C (en) 2003-01-30 2020-01-14 Chiron Srl Injectable vaccines against multiple meningococcal serogroups
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
EP1689867A4 (de) * 2003-11-20 2007-08-22 Sanofi Pasteur Ltd Immunisierung gegen infektion mit chlamydia
CN101060852A (zh) * 2004-08-17 2007-10-24 亨特免疫有限公司 口服灭活疫苗及其提供方法
EP1812055A4 (de) * 2004-11-11 2008-09-03 Univ Queensland Chlamydien-antigene und ihre verwendungen
EP2433647A3 (de) 2005-01-27 2012-06-06 Children's Hospital & Research Center at Oakland Gna1870-basierte vesikelimpfstoffe für breitbandschutz gegen neisseria meningitidis-bedingte erkrankungen
BRPI0609547A2 (pt) * 2005-03-31 2011-10-18 Glaxosmithkline Biolog Sa composição, uso de uma composição, método para o tratamento ou prevenção de infecção por chlamydia, uso de uma ou mais proteìnas de chlamydia, de fragmentos imunogênicos das mesmas ou de polinucleotìdeos codificando os mesmos, método para o tratamento ou prevenção de infecção por chlamydia, e, método para a determinação prévia de infecção por chlamydia em um indivìduo
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
WO2007030879A1 (en) * 2005-09-13 2007-03-22 Diatech Pty Ltd Diagnostic markers and uses therefor
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
WO2007082105A2 (en) * 2006-01-16 2007-07-19 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chlamydia vaccine
EP2886551A3 (de) 2008-02-21 2015-09-23 Novartis AG Meningokokken-FHBP-Polypeptide
US9387239B2 (en) * 2008-05-30 2016-07-12 U.S. Army Medical Research And Materiel Command Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
US20120135039A1 (en) * 2008-10-08 2012-05-31 Aldwell Frank E Oral Vaccines for Producing Mucosal Immunity
CA2787697C (en) * 2009-01-29 2018-03-20 British Columbia Cancer Agency Branch Compositions comprising chlamydia antigens
NZ598458A (en) 2009-08-27 2014-03-28 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
CN102917730A (zh) 2009-10-27 2013-02-06 诺华有限公司 修饰的脑膜炎球菌fHBP多肽
GB201009861D0 (en) 2010-06-11 2010-07-21 Novartis Ag OMV vaccines
CN103635206A (zh) * 2011-04-01 2014-03-12 美国佛罗里达大学研究基金会公司 用于局部给药治疗的热敏、黏膜附着或皮膜附着以及渗透促进调配物
LT3110442T (lt) 2014-02-28 2020-12-28 Glaxosmithkline Biologicals Sa Modifikuoti meningokokinio fhbp polipeptidai
CN106714827A (zh) * 2014-10-02 2017-05-24 日东电工株式会社 经皮给药用疫苗药物组合物
US10596247B2 (en) * 2015-02-20 2020-03-24 Board Of Regents, The University Of Texas System Methods and compositions for attenuated chlamydia as vaccine and vector

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180111B1 (en) * 1995-05-18 2001-01-30 University Of Maryland Vaccine delivery system
US6558677B2 (en) * 1996-10-15 2003-05-06 Wendell D. Zollinger Vaccine against gram negative bacteria
US6607730B1 (en) * 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
US6565856B1 (en) * 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
US7125718B2 (en) * 2000-05-24 2006-10-24 University Of Maryland Biotechnology Institute Method for introducing and expressing genes in animal cells, and bacterial blebs for use in same

Also Published As

Publication number Publication date
AU2002244710A1 (en) 2002-08-19
US20050281847A1 (en) 2005-12-22
ATE357249T1 (de) 2007-04-15
GB0103169D0 (en) 2001-03-28
US20040131625A1 (en) 2004-07-08
ES2284840T3 (es) 2007-11-16
WO2002062380A2 (en) 2002-08-15
CA2436435A1 (en) 2002-08-15
EP1383534B1 (de) 2007-03-21
EP1383534A2 (de) 2004-01-28
DE60218998T2 (de) 2007-12-06
WO2002062380A3 (en) 2003-10-23
JP2004527480A (ja) 2004-09-09

Similar Documents

Publication Publication Date Title
DE60218998D1 (de) Auf Bläschen basierendes Impfstoff gegen Chlamydia
WO2002009746A3 (en) Vaccines comprising outer membrane vesciles from gram negative bacteria
ATE295180T1 (de) Zubereitung zur immunisierung gegen den aids- virus
EP1594536A4 (de) Adjuvante influenza-vakzine
WO2004015099A3 (en) Vaccine composition comprising lipooligosaccharide with reduced phase variability
NO20026064D0 (no) Nye forbindelser
IL171914A0 (en) Variants of il-18bp, their preparation and pharmaceutical compositions containing them
SE0104251D0 (sv) Novel compounds
SE0301653D0 (sv) Novel compounds
SE0302139D0 (sv) Novel compounds
AU2002353775A1 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
ATE308991T1 (de) Bakterieller impfstoff
DE60239318D1 (de) Antibakterielle impfstoffzusammensetzungen
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
WO2006113907A3 (en) Escherichia coli o157:h7 proteins and uses thereof
JP2006512078A5 (de)
SE0003476D0 (sv) Compounds
SE0303280D0 (sv) Novel compounds
ATE380557T1 (de) E. coli vakzin zur protektion von geflügel gegen colibazillose
ATE462779T1 (de) Nukleinsäurefreie ghost zusammensetzungen
DK1740206T3 (da) PHEP, en aminosyrepermease af Staphylococcus Aureus
WO2002057281A3 (en) Aminoglycosides as antibiotics
MY137258A (en) Bacterial insecticidal protein
BRPI0414884A (pt) derivados 3-isopropil-1-metilciclopentila e seu uso em aplicações com fragráncias

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: BERTHET, JACQUELINE, RIXENSART, BE

Inventor name: LOBET, YVES, RIXENSART, BE

Inventor name: POOLMAN, JAN, RIXENSART, BE

Inventor name: VERLANT, VINCENT, RIXENSART, BE

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee